These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 10460804

  • 1. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
    Nebbia C, Ceppa L, Dacasto M, Carletti M, Nachtmann C.
    Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
    [Abstract] [Full Text] [Related]

  • 2. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M, Shindo M, Shimada T.
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [Abstract] [Full Text] [Related]

  • 3. Biochemical background of toxic interaction between tiamulin and monensin.
    Szucs G, Tamási V, Laczay P, Monostory K.
    Chem Biol Interact; 2004 Mar 15; 147(2):151-61. PubMed ID: 15013817
    [Abstract] [Full Text] [Related]

  • 4. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.
    Drug Metab Dispos; 2000 Sep 15; 28(9):1128-34. PubMed ID: 10950860
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C, Gelboin HV, Park SS, Pearce R, Parkinson A, Kupfer D.
    Drug Metab Dispos; 1993 Sep 15; 21(4):645-56. PubMed ID: 8104124
    [Abstract] [Full Text] [Related]

  • 6. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR.
    Drug Metab Dispos; 1999 Aug 15; 27(8):902-8. PubMed ID: 10421617
    [Abstract] [Full Text] [Related]

  • 7. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS, Hauswald C, Oppermann JA, Schoenhard GL.
    J Pharmacol Exp Ther; 1993 Jul 15; 266(1):1-7. PubMed ID: 8331551
    [Abstract] [Full Text] [Related]

  • 8. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA, Syrek M, Ryłko Z, Wójcikowski J.
    Pol J Pharmacol; 2001 Jul 15; 53(4):351-7. PubMed ID: 11990081
    [Abstract] [Full Text] [Related]

  • 9. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.
    Cancer Res; 2000 Jun 15; 60(12):3232-8. PubMed ID: 10866316
    [Abstract] [Full Text] [Related]

  • 10. Induction of liver cytochrome P-450 (CYP) 3A in male and female rats by a steroidal androgen receptor antagonist, zanoterone.
    Roberts AE, Ritz MA, Hoekstra S, Descotes G, Hincks JR.
    J Biochem Toxicol; 1996 Jun 15; 11(3):101-10. PubMed ID: 9029268
    [Abstract] [Full Text] [Related]

  • 11. Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans.
    Kashiyama E, Yokoi T, Odomi M, Funae Y, Inoue K, Kamataki T.
    Drug Metab Dispos; 1997 Jun 15; 25(6):716-24. PubMed ID: 9193873
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
    Chang T, Levine M, Bandiera SM, Bellward GD.
    J Pharmacol Exp Ther; 1992 Mar 15; 260(3):1441-9. PubMed ID: 1545403
    [Abstract] [Full Text] [Related]

  • 13. Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats.
    Nebbia C, Ceppa L, Dacasto M, Nachtmann C, Carletti M.
    J Vet Pharmacol Ther; 2001 Dec 15; 24(6):399-403. PubMed ID: 11903870
    [Abstract] [Full Text] [Related]

  • 14. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes.
    Narimatsu S, Tachibana M, Masubuchi Y, Suzuki T.
    Chem Res Toxicol; 1996 Dec 15; 9(1):93-8. PubMed ID: 8924622
    [Abstract] [Full Text] [Related]

  • 15. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
    Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, Hall SD.
    J Pharmacol Exp Ther; 1999 Sep 15; 290(3):1116-25. PubMed ID: 10454485
    [Abstract] [Full Text] [Related]

  • 16. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem.
    Pichard L, Gillet G, Fabre I, Dalet-Beluche I, Bonfils C, Thenot JP, Maurel P.
    Drug Metab Dispos; 1990 Sep 15; 18(5):711-9. PubMed ID: 1981725
    [Abstract] [Full Text] [Related]

  • 17. Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes.
    Sarver JG, Bachmann KA, Zhu D, Klis WA.
    Drug Metab Dispos; 1998 Jan 15; 26(1):78-82. PubMed ID: 9443857
    [Abstract] [Full Text] [Related]

  • 18. Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .
    Lin JH, Chiba M, Chen IW, Nishime JA, deLuna FA, Yamazaki M, Lin YJ.
    Drug Metab Dispos; 1999 Oct 15; 27(10):1187-93. PubMed ID: 10497146
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M.
    Drug Metab Dispos; 2001 Feb 15; 29(2):145-51. PubMed ID: 11159804
    [Abstract] [Full Text] [Related]

  • 20. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle.
    Zweers-Zeilmaker WM, Van Miert AS, Horbach GJ, Witkamp RF.
    Res Vet Sci; 1999 Feb 15; 66(1):51-5. PubMed ID: 10088712
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.